Regeneron Pharma (REGN) Posts Q1 Loss of $0.49, Wider than Views
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $789.45 --0%
Revenue Growth %: +21.1%
Financial Fact:
Selling, general, and administrative: 270.05M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +21.1%
Financial Fact:
Selling, general, and administrative: 270.05M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) reported Q1 loss of ($0.49), $0.13 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $112.2 million versus the consensus estimate of $117.02 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lennar Corp. (LEN) Misses Q3 EPS by 10c
- Dave & Buster's Entertainment (PLAY) Misses Q2 EPS by 46c
- Regeneron Pharma (REGN) PT Raised to $920 at HSBC
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
